One leading broker has very good things to say about these buy-rated shares. The post 2 of the best ASX 200 blue chip shares to buy with $2,000 appeared first on The Motley Fool Australia.

Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...

The Trump Administration's 10% tariff on all Chinese imports took effect on Feb. 4. Many unknowns remain, but Americans will ...

Treat yourself to the viral beauty tool that fans say cuts their hair drying time to only 10 minutes. And get $100 off the ...

Editorial written by Pittsburgh Post-Gazette Board. The avian flu pandemic ravaging poultry farms across the country, raising the price of eggs and wings is an act of nature, but the human response to ...

If you love all things butter, then you’re in for a treat. KitchenAid’s Color of the Year is Butter, and it’s almost as rich and creamy as the real thing. You can pick up the brand’s iconic 5-Quart ...

Readers worry that fraud may tarnish the field and slow the race for a cure. Also: Charles Blow’s farewell; treatment for ...

Maxim initiated coverage of Kazia Therapeutics (KZIA) with a Buy rating and $3 price target The company’s lead asset is paxalisib, a potent, ...

Its cash, cash equivalents, and short-term marketable securities balance was around $1.2 billion in 2022, and we expect the trend of no/low debt and deep pockets of cash to continue over the next five ...

Financial writer recommends Crispr Therapeutics AG as a strong buy due to cash position, drug pipeline, and promising ...

You can also save up to 50% on the Sony ULT Wear headphones, Sonos Ray, Blink Mini 2, and Anker Zolo power bank.